Financial Disclosures The COPHy EU Congress seeks to balance the important benefits of physician-industry relationships with the potential risk that the financial goals of the industry may conflict with the professional goals of COPHy EU participants. In doing so, the COPHy EU Congress recognizes that it has a profound duty to its participants, the larger medical community and the public to ensure the integrity of all of its scientific, educational, and advocacy activities and materials. Educational Content Development The COPHy EU Congress requires all program members and any others in a position to control the educational content to disclose any commercial financial interests prior to the development of the educational content. A process of resolution of conflict of interest is used for those members who do have financial interests related to the development of the content. Presenters The COPHy EU Congress considers financial relationships to create actual conflicts of interest when Presenters or their immediate family (defined as spouse, domestic partner, parent, child or spouse of child, or sibling or spouse of sibling of the Presenter) have both a financial relationship with a commercial interest and the opportunity to affect the policy of the COPHy EU Congress of CME about the products or services of that commercial interest. The potential for Presenter to maintaining or increasing the value of the financial relationship with the commercial interest creates an incentive to influence the content of the CME – an incentive to insert commercial bias. All presenters of CME content should familiarize themselves with the policy of the COPHy EU Congress of CME based on the CME provider of the Congress – the EACCME (http://www.eaccme.AA/uemspdf/UEMS-2012-30.pdf ). All COPHy Faculty presenting CME are required to disclose to the activity audience the following information prior to beginning their presentation: . Any relevant financial relationships a CME presenter has had with manufacturers of commercial ophthalmic products or providers of commercial ophthalmic services within the past 12 months. The COPHy Congress defines "relevant" financial relationships as those with a commercial ophthalmic interest and the opportunity to affect the content of CME about the products or services of that commercial ophthalmic interest . CME presenters who report they have no known relevant financial relationships to disclose will declare "No Financial Relationships" NOTE: All presenters are required to report financial disclosures, using the codes below. An individual's financial disclosures for the 5th COPHy EU Congress meeting are listed in this Section. COPHy Financial Disclosure Codes Category Code Description None N No financial relationships reported Consultant C Consultant fee, paid advisory boards Advisor fees for attending a meeting (for the past 1 year) Employee E Employed by a commercial entity Lecture fees L Lecture fees (honoraria), travel fees or reimbursements when Speaking at the invitation of a commercial entity (for the past 1 year) Equity owner O Equity ownership/stock options or publicly or privately traded firms (excluding mutual funds) with manufacturers of commercial ophthalmic products or providers of commercial ophthalmic services Patents / P Patents and/or royalties that might be viewed as creating a Royalty potential conflict of interest Grant support S Grant support for the past 1 year (all sources) \ Used for this project if this form is an update for a specific talk or publication with no time limitation Disclosure Information Financial interest disclosures from program members and others in a position for control content: Luis Arias, Spain Susan Bressler, USA Faculty Member Faculty Member No financial relationships reported N Bayer S Biocon S Francesco Bandello, Italy Biophytis S Faculty Member Boehringer-Inglehim S Allergan C Genentech S Bayer C Mylan S Boehringer Ingelheim C Notal S Fidia Sooft C Novartis S Hofmann-La Roche C Merck S Novartis C NTC Pharma C Josep Caminal, Spain SIFI C Faculty Member Thrombogenics C Financial relationships pending Zeiss C Angela Carniero, Portugal João Barbosa Breda, Portugal RAB, Faculty Member Faculty Member Alimera Sciences C Aerie C Allergan C Allergan C Bayer C Novartis C Bahram Bodaghi, France Roche C Faculty Member Alimera C Usha Chakravarthy, UK Allergan C Faculty Member Bayer S No financial relationships reported N Novartis S Santen C Francesca Cordeiro, UK Thea C Faculty Member Financial relationships pending Francesco Boscia, Italy Faculty Member José Cunha-Vaz, Portugal Financial relationships pending RAB, Faculty Member Aerpio Therapeutics C Neil Bressler, USA Alimera Sciences C Co-Chair, Faculty Member Allergan C Bayer S Bayer C Genetech/Roche S Boehringer Ingelheim C Novartis S Novartis C Samsung Bioepis S Oxular Limited C Bayer S Zeiss Meditec C Bertil Damato, UK Faculty Member Aura Biosciences C Immunocore C Pfizer O Eugene de Juan, USA Baruch Kuppermann, USA Faculty Member Faculty Member No financial relationships reported N Alimera Sciences C Allegro Opthalmics, LLC S, C Nicole Eter, Germany Allergan S, C, L Faculty Member Apellis Pharmaceuticals S Allergan L Cell Care Therapeutics C Bayer C, L, S Dose Medical Corporation C Novartis C, L, S Eyedaptic C Roche C, L Galimedix C Genentech, Inc S, C António Figueiredo, Portugal Glaukos Corporation C Faculty Member Interface Biologics C No financial relationships reported N Ionis Pharmaceuticals S, C IVERIC Bio/Ophthotech Corporation C Pedro Fonseca, Portugal jCyte S RAB, Faculty Member Novartis C No financial relationships reported N Ocunexus Therapeutics C Regeneron Pharmaceuticals, Inc S Stratos Gotzaridis, Greece Re-Vana Therapeutics C Faculty Member Theravance Biopharma C Financial relationships pending Paolo Lanzetta, Italy Zohar Habot-Wilner, Israel Faculty Member Faculty Member Allegro C No financial relationships reported N Bayer C, S Centervue C Anton Hommer, Austria Novartis C Faculty Member No financial relationships reported N Len Levin, Canada Faculty Member Peter Kertes, Canada Aerie C Faculty Member Eyevensys C Allergan S Galimediux C Arcticdx O Prilenia C Bayer C, L, S Quark C Novartis C, L, S Regenera S Regeneron Pharmaceuticals S Santen C Roche S Anat Loewenstein, Israel Jean-Francois Korobelnik, France Co-Chair, Faculty Member Faculty Member Allergan S Allergan C Bayer S Bayer C Forsight S KangHong C Notal Vision S Novartis C Novartis S Roche C Dália Meira, Portugal Faculty Member No financial relationships reported N Stephan Michels, Switzerland Hendrik Scholl, Switzerland Faculty Member Faculty Member Allergan AG C Swiss National Science Foundation S Bayer AG C National Center of Competence in S Research Molecular Systems Engineering Novartis AG C The Wellcome Trust S Ophthorobotics AG O The Foundation Fighting Blindness S Clinical Research Institute Roche AG C Astellas C Gensight Biologics C William Mieler, USA Ionis Pharmaceuticals C Faculty Member Gyroscope Therapeutics C No financial relationships reported N ReNeuron Group PLC/Ora Inc C Vision Medicines Inc C Neil Miller, USA Gerson Lehrman Group C Faculty Member Guidepoint C Quark Pharmaceuticals C NovoNordisk C Regenera Pharmaceutical C Novartis S Kinarus AG S Joseph Moisseiev, Israel Novartis Phrama AG S Faculty Member Ophthotech Corporation S No financial relationships reported N Roche S Spark Therapeutics S Jordi Mones, Spain RAB, Faculty Member Eduardo Silva, Portugal Financial relationships pending RAB, Faculty Member No financial relationships reported N Carlos Pavesio, UK Faculty Member Rufino Silva, Portugal AbbVie C, L RAB, Faculty Member Alimera C, L Alimera C Allergan C, L Allergan C Bayer C Stanislao Rizzo, Italy Novartis C Faculty Member Thea C No financial relationships reported N Michael Stewart, USA Mandeep Sagoo, UK Faculty Member Faculty Member Allergan S No financial relationships reported N Alkahest L Bayer C, L Kanghong S Santen S Patricia Udaondo, Spain RAB, Faculty Member Alimera C Allergan C Bausch and Lomb C Bayer C Brill C Graybug Vision C Novartis C Roche C, S Stela Vujosevic, Italy Faculty Member Allergan C Bayer C Novartis C Novonordisk C Sandrine Zweifel, Switzerland Faculty Member No financial relationships reported N .